HKU and China Merchants Group Forge Partnership in Peptide Drug Innovation
The University of Hong Kong (HKU), the commercial wing represented by Versitech Limited, formalised a significant agreement with China Merchants Group (CMG) on peptide drug innovation and discovery on 27 November 2024.